IBDEI1PS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30731,0)
 ;;=N40.0^^189^1922^6
 ;;^UTILITY(U,$J,358.3,30731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30731,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,30731,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,30731,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,30732,0)
 ;;=N42.89^^189^1922^33
 ;;^UTILITY(U,$J,358.3,30732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30732,1,3,0)
 ;;=3^Prostate Disorders NEC
 ;;^UTILITY(U,$J,358.3,30732,1,4,0)
 ;;=4^N42.89
 ;;^UTILITY(U,$J,358.3,30732,2)
 ;;=^270425
 ;;^UTILITY(U,$J,358.3,30733,0)
 ;;=N41.9^^189^1922^23
 ;;^UTILITY(U,$J,358.3,30733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30733,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,30733,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,30733,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,30734,0)
 ;;=N43.3^^189^1922^22
 ;;^UTILITY(U,$J,358.3,30734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30734,1,3,0)
 ;;=3^Hydrocele,Unspec
 ;;^UTILITY(U,$J,358.3,30734,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,30734,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,30735,0)
 ;;=N47.1^^189^1922^32
 ;;^UTILITY(U,$J,358.3,30735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30735,1,3,0)
 ;;=3^Phimosis
 ;;^UTILITY(U,$J,358.3,30735,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,30735,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,30736,0)
 ;;=N47.2^^189^1922^31
 ;;^UTILITY(U,$J,358.3,30736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30736,1,3,0)
 ;;=3^Paraphimosis
 ;;^UTILITY(U,$J,358.3,30736,1,4,0)
 ;;=4^N47.2
 ;;^UTILITY(U,$J,358.3,30736,2)
 ;;=^90023
 ;;^UTILITY(U,$J,358.3,30737,0)
 ;;=N52.9^^189^1922^16
 ;;^UTILITY(U,$J,358.3,30737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30737,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,30737,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,30737,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,30738,0)
 ;;=N52.8^^189^1922^11
 ;;^UTILITY(U,$J,358.3,30738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30738,1,3,0)
 ;;=3^Erectile Dysfunction NEC
 ;;^UTILITY(U,$J,358.3,30738,1,4,0)
 ;;=4^N52.8
 ;;^UTILITY(U,$J,358.3,30738,2)
 ;;=^5015762
 ;;^UTILITY(U,$J,358.3,30739,0)
 ;;=N52.39^^189^1922^15
 ;;^UTILITY(U,$J,358.3,30739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30739,1,3,0)
 ;;=3^Erectile Dysfunction,Post-Surgical NEC
 ;;^UTILITY(U,$J,358.3,30739,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,30739,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,30740,0)
 ;;=N52.34^^189^1922^9
 ;;^UTILITY(U,$J,358.3,30740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30740,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,30740,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,30740,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,30741,0)
 ;;=N52.33^^189^1922^10
 ;;^UTILITY(U,$J,358.3,30741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30741,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,30741,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,30741,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,30742,0)
 ;;=N52.32^^189^1922^7
 ;;^UTILITY(U,$J,358.3,30742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30742,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,30742,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,30742,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,30743,0)
 ;;=N52.31^^189^1922^8
 ;;^UTILITY(U,$J,358.3,30743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30743,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,30743,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,30743,2)
 ;;=^5015757
